Advertisement
Concise Publication Free access | 10.1172/JCI107525
1Department of Pathology, New York University School of Medicine, New York 10016
Find articles by Eden, A. in: JCI | PubMed | Google Scholar
1Department of Pathology, New York University School of Medicine, New York 10016
Find articles by Miller, G. in: JCI | PubMed | Google Scholar
1Department of Pathology, New York University School of Medicine, New York 10016
Find articles by Nussenzweig, V. in: JCI | PubMed | Google Scholar
Published December 1, 1973 - More info
Human peripheral blood lymphocytes have membrane receptors for EAC43b (sheep erythrocytes sensitized with antibody and complement) and also for EAC43d, obtained by treating EAC43b with C3b inactivator. Human granulocytes bind only EAC43b, C3 fragments obtained by limited trypsin digestion of purified human C3 display both C3b and C3d sites, since they inhibit rosette formation of lymphocytes with EAC43b and EAC43d. These findings raise the possibility that C3b and C3d receptor sites may be selectively distributed among normal subpopulations of B lymphocytes as well as among leukemic leukocytes.
Click on an image below to see the page. View PDF of the complete article